OpenBilldrug price receipt

NADAC week of 2026-10-14

RANOLAZINE ER 1,000 MG TABLET

For 30 tablets

Pharmacies pay

$8.23 filed

30 × $0.27428 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$23.53 filed

30 × $0.78436 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.9× estimated

Medicare paid 2.9× what pharmacies pay.

Part D averages every strength and form sold under “Ranolazine ER” / “Ranolazine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$14.46 estimated

$8.23 + $1.23 (15%) + $5.00 fee per fill = $14.46

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

RANOLAZINE ER 1,000 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ranolazine.

FDA gives its dosage form as “tablet, extended release” and “tablet, film coated, extended release” and its route as oral.

FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Ajanta Pharma USA Inc., Camber Pharmaceuticals, Inc. and ScieGen Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Anti-anginal.

The NADAC file of 2026-10-14 prices it under 14 NDCs (National Drug Codes); the FDA directory lists 13 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $8.23 for 30 tablets (30 × $0.27428 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 12 labelers

LabelerNDCsPharmacies pay per unit
Ajanta Pharma USA Inc.2$0.27428 per EA filed
Ascend Laboratories, LLC1$0.27428 per EA filed
Aurobindo Pharma Limited1$0.27428 per EA filed
AvPAK1$0.27428 per EA filed
Camber Pharmaceuticals, Inc.1$0.27428 per EA filed
Glenmark Pharmaceuticals Inc., USA1$0.27428 per EA filed
Lifestar Pharma LLC1$0.27428 per EA filed
ScieGen Pharmaceuticals, Inc1$0.27428 per EA filed
Viona Pharmaceuticals Inc1$0.27428 per EA filed
Westminster Pharmaceuticals, LLC1$0.27428 per EA filed
Zameer Pharmaceuticals LLC1$0.27428 per EA filed
i3 Pharmaceuticals, LLC1$0.27428 per EA filed
Not listed as a package in the FDA directory1$0.27428 per EA filed
All 14 NDCs, with labeler and price
  • 27241-0126-02 · Ajanta Pharma USA Inc. · $0.27428 per EA · eff. 2026-09-23 filed
  • 27241-0126-05 · Ajanta Pharma USA Inc. · $0.27428 per EA · eff. 2026-09-23 filed
  • 31722-0669-60 · Camber Pharmaceuticals, Inc. · $0.27428 per EA · eff. 2026-09-23 filed
  • 50228-0424-60 · ScieGen Pharmaceuticals, Inc · $0.27428 per EA · eff. 2026-09-23 filed
  • 50268-0723-11 · not listed as a package in the FDA directory · $0.27428 per EA · eff. 2026-09-23 filed
  • 50268-0723-13 · AvPAK · $0.27428 per EA · eff. 2026-09-23 filed
  • 59651-0010-60 · Aurobindo Pharma Limited · $0.27428 per EA · eff. 2026-09-23 filed
  • 67877-0526-60 · Ascend Laboratories, LLC · $0.27428 per EA · eff. 2026-09-23 filed
  • 68462-0320-60 · Glenmark Pharmaceuticals Inc., USA · $0.27428 per EA · eff. 2026-09-23 filed
  • 69367-0294-60 · Westminster Pharmaceuticals, LLC · $0.27428 per EA · eff. 2026-09-23 filed
  • 70756-0704-60 · Lifestar Pharma LLC · $0.27428 per EA · eff. 2026-09-23 filed
  • 72319-0022-02 · i3 Pharmaceuticals, LLC · $0.27428 per EA · eff. 2026-09-23 filed
  • 72578-0065-14 · Viona Pharmaceuticals Inc · $0.27428 per EA · eff. 2026-09-23 filed
  • 90096-0152-60 · Zameer Pharmaceuticals LLC · $0.27428 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name ranolazine with RANOLAZINE ER 1,000 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
RANOLAZINE ER 1,000 MG TABLET this page
generic · tablet, extended release / tablet, film coated, extended release
$0.27428 per EA filed
eff. 2026-09-23
$0.78436 per EA filed
Part D 2024 average
RANOLAZINE ER 500 MG TABLET
generic · tablet, film coated, extended release / tablet, extended release
$0.16493 per EA filed
eff. 2026-09-23
$0.78436 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $23.53 for 30 tablets, at an average of $0.78436 per EA in 2024 (2024-01-01 to 2024-12-31) for “Ranolazine ER” and “Ranolazine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,248,783 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for RANOLAZINE ER 1,000 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Ranolazine ER / Ranolazine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.